ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

ClinicalTrials.gov ID: NCT06848348

Public ClinicalTrials.gov record NCT06848348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Study identification

NCT ID
NCT06848348
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dogwood Therapeutics Inc.
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • Halneuron Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2025
Primary completion
Jun 30, 2026
Completion
Jul 31, 2026
Last update posted
Jan 11, 2026

2025 – 2026

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Central Recruiting Site Sheffield Alabama 35660 Recruiting
Central Recruiting Site Glendale Arizona 85308 Recruiting
Central Recruiting Site Fair Oaks California 95628 Recruiting
Central Recruiting Site Fountain Valley California 92708 Recruiting
Central Recruiting Site Los Angeles California 91307 Recruiting
Central Recruiting Site Santa Rosa California 95403 Recruiting
Central Recruiting Site Wheat Ridge Colorado 80033 Recruiting
Central Recruiting Site Jacksonville Florida 32205 Recruiting
Central Recruiting Site Jacksonville Florida 32256 Recruiting
Central Recruiting Site Lakeland Florida 33812 Recruiting
Central Recruiting Site Orlando Florida 32832 Recruiting
Central Recruiting Site Port Charlotte Florida 33952 Recruiting
Central Recruiting Site Tampa Florida 33613 Recruiting
Central Recruiting Site Atlanta Georgia 30331 Recruiting
Central Recruiting Site Gurnee Illinois 60031 Recruiting
Central Recruiting Site Farmington Michigan 48334 Recruiting
Central Recruiting Site Fenton Missouri 63026 Recruiting
Central Recruiting Site Kansas City Missouri 64111 Recruiting
Central Recruiting Site Las Vegas Nevada 89109 Recruiting
Central Recruiting Site Garden City New York 11530 Recruiting
Central Recruiting Site Williamsville New York 14221 Recruiting
Central Recruiting Site Winston-Salem North Carolina 27103 Recruiting
Central Recruiting Site Salt Lake City Utah 84107 Recruiting
Central Recruiting Site Madison Wisconsin 53715 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06848348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06848348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →